About
1. Blogger on Diabetes, Mutiple Sclerosis, Novartis history/annual reports and how AI…
Activity
-
graphicalMCP made it to CRAN! Hope this will make our R package more accessible for graphical multiple comparison procedures. Its flexible to use…
graphicalMCP made it to CRAN! Hope this will make our R package more accessible for graphical multiple comparison procedures. Its flexible to use…
Liked by Tuochuan Dong/董拓川
-
Our 1st year data of AVT001 for Type 1 Diabetes has been published by NEJM Evidence! Here is the paper: https://lnkd.in/ebNG-9Nd And here is our…
Our 1st year data of AVT001 for Type 1 Diabetes has been published by NEJM Evidence! Here is the paper: https://lnkd.in/ebNG-9Nd And here is our…
Shared by Tuochuan Dong/董拓川
-
We're excited to announce our up to $1.2B multi-target collaboration and exclusive license agreement with Takeda. For specific targets selected by…
We're excited to announce our up to $1.2B multi-target collaboration and exclusive license agreement with Takeda. For specific targets selected by…
Liked by Tuochuan Dong/董拓川
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
State University of New York at Buffalo
-
1. Developed a strong ability of self-learning and research.
2. Learned main stream statistical theories and specialized in the application of diagnostic test and clinical trials. -
-
1. Developed the ability to harmoniously deal with different opinions and disagreements.
2. Learned a little about mathematics and the basics about statistics. -
-
1. High school education, grew into a non-self-centered person.
2. Ranked in the top 10/700 students in most of the final exams of each semester.
3. Won a National First Grade Prize at the province level (Sichuan) in the Chinese National Chemistry Olympiad Contest.
4. Scored 667/750 in year 2004 National Higher Education Entrance Examination.
Volunteer Experience
-
Mentor
Novartis
- 2 years 9 months
Education
Novartis After-School Mentoring Program
Three-years mentoring program with students from East Hanover Central Elementary School, from their 3rd grade to the 5th grade -
VP of Operations
BIOKATALYST A NEW JERSEY NONPROFIT CORPORATION
- Present 6 years 8 months
Lead the operations and logistics in event organization and reporting for the club.
Publications
-
A new diagnostic accuracy measure and cut-off point(s) selection criterion.
Statistical Methods in Medical Research
Other authors -
-
Confidence interval estimation for sensitivity to the early disease stage based on empirical likelihood.
Journal of Biopharmaceutical Statistics
Other authors -
-
Confidence interval estimation of the difference between two sensitivities to the early disease stage.
Biometrical Journal
Other authors -
-
Parametric and non-parametric confidence intervals of the probability of identifying early disease stage given sensitivity to full disease and specificity with three ordinal diagnostic groups.
Statistics in Medicine
Other authors -
Languages
-
English
Full professional proficiency
-
Chinese
Native or bilingual proficiency
Organizations
-
BioKatalyst
Junior Volunteer
- PresentJunior Volunteer for BioKatalyst. Eager to learn and grow my business expertise.
-
SAPA (Sino-American Pharmaceutical Professionals Assosciation)
Member
- PresentLifetime SAPA membership, active participants in all the events organized by SAPA.
-
ASA
-
- Present
More activity by Tuochuan
-
Inspired by the FDA guidance on covariate adjustment, here is our new paper to analyzing risk difference with a focus on small sample performances…
Inspired by the FDA guidance on covariate adjustment, here is our new paper to analyzing risk difference with a focus on small sample performances…
Liked by Tuochuan Dong/董拓川
-
I am excited to share that I spoke yesterday at the plenary session of the 5th International Cell & Gene Therapy China Summit, where I joined a group…
I am excited to share that I spoke yesterday at the plenary session of the 5th International Cell & Gene Therapy China Summit, where I joined a group…
Liked by Tuochuan Dong/董拓川
-
On August 1, 1981 - 42 years ago today - I got laid off from the only full-time job I'd ever had, with two months notice. It was embarrassing – none…
On August 1, 1981 - 42 years ago today - I got laid off from the only full-time job I'd ever had, with two months notice. It was embarrassing – none…
Liked by Tuochuan Dong/董拓川
-
Today the US FDA approved our monoclonal antibody to protect all infants through their first RSV season. It means we now have the potential to…
Today the US FDA approved our monoclonal antibody to protect all infants through their first RSV season. It means we now have the potential to…
Liked by Tuochuan Dong/董拓川
-
Medicine has seen incredible breakthroughs in the past decade – with CAR-T cell therapy being perhaps the most significant breakthrough in cancer…
Medicine has seen incredible breakthroughs in the past decade – with CAR-T cell therapy being perhaps the most significant breakthrough in cancer…
Liked by Tuochuan Dong/董拓川
-
After 35+ years, today is my first official day as a Novartis retiree (there must be some mistake, retirees are supposed to be old people 😊). It's…
After 35+ years, today is my first official day as a Novartis retiree (there must be some mistake, retirees are supposed to be old people 😊). It's…
Liked by Tuochuan Dong/董拓川
-
What a stellar night under a crystal blue sky celebrating #bigdata, #rwe and #digital as the winner of the Reuters Events Pharma USA 2022’s Most…
What a stellar night under a crystal blue sky celebrating #bigdata, #rwe and #digital as the winner of the Reuters Events Pharma USA 2022’s Most…
Liked by Tuochuan Dong/董拓川
-
I am really excited that we are one step closer to bringing a potential life-changing therapy to Type I Diabetes patients! https://lnkd.in/ezJnNrmF
I am really excited that we are one step closer to bringing a potential life-changing therapy to Type I Diabetes patients! https://lnkd.in/ezJnNrmF
Shared by Tuochuan Dong/董拓川
-
A great milestone achieved! Looking forward to more good news in the coming year, to bring obe-cel closer to the patients! Thanks a lot to all the…
A great milestone achieved! Looking forward to more good news in the coming year, to bring obe-cel closer to the patients! Thanks a lot to all the…
Liked by Tuochuan Dong/董拓川
-
Today marks the end of one chapter and the beginning of a new one in my career. It is not often that we get the chance to slow down, reflect on our…
Today marks the end of one chapter and the beginning of a new one in my career. It is not often that we get the chance to slow down, reflect on our…
Liked by Tuochuan Dong/董拓川
-
We’ve reached a critical juncture in healthcare. Now more than ever, patients are taking charge of their own healthcare, while at the same time…
We’ve reached a critical juncture in healthcare. Now more than ever, patients are taking charge of their own healthcare, while at the same time…
Liked by Tuochuan Dong/董拓川
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More